| 摘要 |
<p>An adjuvant containing as the active ingredient an attenuated toxin having a residual activity of 1/2000 or less than the activity of the natural toxin; and vaccines containing this adjuvant. By using, for example, attenuated natural cholera toxin, vaccines capable of showing sufficient immune enhancement in percutaneous vaccination or nasal vaccination can be presented.</p> |
